(Q34035251)

30 July 2017

title

Generic legislation of new psychoactive drugs (English)

1 reference

30 July 2017

David Nutt

2

0 references

Wim van den Brink

series ordinal

3

object named as

Wim van den Brink

1 reference

30 July 2017

Jan van Amsterdam

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

23 January 2013

1 reference

Journal of Psychopharmacology

30 July 2017

published in

1 reference

30 July 2017

volume

27

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

317-324

1 reference

A web-based survey on mephedrone

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881112474525

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112474525

Controlling new drugs under marketing regulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112474525

Cannabidiol: a promising drug for neurodegenerative disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112474525

Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112474525

Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112474525

Perverse effects of the precautionary principle: how banning mephedrone has unexpected implications for pharmaceutical discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112474525

Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112474525

Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112474525

Serotonergic hallucinogens and emerging targets for addiction pharmacotherapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112474525

Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112474525

Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112474525

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112474525

21 January 2018

Identifiers

DOI

10.1177/0269881112474525

1 reference

30 July 2017

1 reference